Drug‐resistant temporal lobe epilepsy: Seizure outcome in children versus adults
Epileptic Disorders · 2026
DOI: 10.1002/epd2.70172 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Epileptic Disorders, 2026. Verfasst von Gurumurthy Bharanidharan und 9 weiteren Autor:innen. Beteiligte Einrichtung: R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology,…. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Drug Resistant Epilepsy, Anterior Temporal Lobectomy, Seizures. Die Arbeit nennt 43 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy, and about two‐thirds of patients with drug‐resistant TLE are surgical candidates. While many studies suggest better postoperative outcomes in children subjected to various types of surgery, there is limited data comparing adults and children who have undergone the same procedure over the same time period. This study aimed to compare long‐term seizure outcomes and identify prognostic factors in pediatric (defined as children less than or equal to 12 years) and adult patients undergoing TLE surgery at a high‐volume epilepsy center in South India.
Methods
The study cohort comprised 684 consecutive patients (127 children, 557 adults) who underwent standard anterior temporal lobectomy. All underwent presurgical evaluation including video EEG, neuroimaging, and surgical decision was made in a multidisciplinary meet. Seizure freedom was defined as “absence of seizures or auras regardless of antiepileptic drug use,” which was the primary outcome. The predictors determining outcome in both age groups were also analyzed. Logistic regression identified the predictors, and Kaplan–Meier curves assessed long‐term seizure‐free survival.
Results
Children had significantly shorter epilepsy duration pre‐surgery (8.38 versus 19.2 years, p < .0001) and significantly better seizure outcome (57.4% vs. 45.6%, p = .0165). Kaplan–Meier analysis revealed longer median seizure‐free survival in children (120 months) than adults (72 months, p = .027). In adults, predictors of poor outcome included auditory aura, behavioral arrest, spike–wave discharges during ictal onset, and bitemporal IEDs. Febrile seizures predicted a favorable outcome in children and adults. In children, neoplasia as a substrate was protective, while psychiatric co‐morbidity and multiple auras predicted seizure recurrence.
Conclusion
Children benefit more from TLE surgery than adults, due to earlier intervention and shorter duration of seizures. The principle of “time is brain” holds true in epilepsy; prolonged duration of uncontrolled seizures fosters network expansion, highlighting the need for “early surgical referral” and “catching them young.”
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.
Zitieren
APA
Bharanidharan, G., Bhasi, A., Abraham, M., Vilanilam, G. C., Menon, R. N., Thomas, B., Kesavadas, C., Nandini, V. S., Basheer, T., & Radhakrishnan, A. (2026). Drug‐resistant temporal lobe epilepsy: Seizure outcome in children versus adults. Epileptic Disorders. https://doi.org/10.1002/epd2.70172
Vancouver
Bharanidharan G, Bhasi A, Abraham M, Vilanilam GC, Menon RN, Thomas B, et al. Drug‐resistant temporal lobe epilepsy: Seizure outcome in children versus adults. Epileptic Disorders. 2026. doi:10.1002/epd2.70172
BibTeX
@article{Bharanidharan2026,
author = {Bharanidharan, Gurumurthy and Bhasi, Ankith and Abraham, Mathew and Vilanilam, George C and Menon, Ramshekhar N and Thomas, Bejoy and Kesavadas, Chandrasekharan and Nandini, Vijayambika Sadasivam and Basheer, Thareekh and Radhakrishnan, Ashalatha},
title = {Drug‐resistant temporal lobe epilepsy: Seizure outcome in children versus adults},
journal = {Epileptic Disorders},
year = {2026},
doi = {10.1002/epd2.70172}
}
EUVIMED